Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLORIOUS: Exenatide and Oxygenation in Heart Surgery
NCT02673931Active, not recruiting
- Sponsor
- Rigshospitalet
- Start
- Feb 2016
- Primary completion
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of exenatide in coronary artery disease (CAD) and aortic valve disease (AVD), sponsored by Rigshospitalet. Started Feb 2016; status: active, not recruiting.
02
Drugs
exenatide
03
Conditions
coronary artery disease (CAD)aortic valve disease (AVD)
Beyond the preview
Go deeper on NCT02673931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673931.